Internal carotid artery near-total occlusions: Is it justified to operate on them?

Similar documents
Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective)

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI

Endovascular treatment for pseudoocclusion of the internal carotid artery

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease

Carotid Artery Stenosis

MEET Θ symptomatic patients. K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany

Management of carotid near-occlusion and acute carotid. occlusion

The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

Carotid Artery Stenting

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund

For the ICSS Investigators. 7 th Munich Vascular Conference Munich, 7 December 2017

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

CLINICAL TIMELINE EVA-3S CREST ICSS SPACE SAPPHIRE

Carotid Artery Stenting Versus

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Will guidelines and clinical practice for asymptomatic stenosis change in the near future?

ESC Heart & Brain Workshop

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

MRI carotid plaque imaging predicts future stroke in patients with mild to moderate stenosis ICAD study

Carotid Artery Stent: Is it ready for prime time?

How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention

LARGE ARTERY DISEASE pathophysiology of ischemic insults. ISCHEMIC STROKE & TIA main etiologies

The CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent

BULgarian Carotid Artery Stenting versus Surgery Study (BULCASSS): Randomized single center trial

Carotid Imaging. Dr Andrew Farrall. Consultant Neuroradiologist

ICSS Safety Results NOT for PUBLICATION. June 2009 ICSS ICSS ICSS ICSS. International Carotid Stenting Study: Main Inclusion Criteria

Carotid Artery Stenting Today: A Few Updating Remarks

ISCHEMIC STROKE & TIA main etiologies

Clinical experience amongst surgeons in the Asymptomatic Carotid Surgery Trial-1 (ACST-1)

CEA or CAS for asymptomatic carotid stenosis which patients benefit most?

Contemporary Management of Carotid Disease What We Know So Far

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

Pitfalls in the evaluation of carotid artery stenosis. Serge Kownator «Centre Cardiologique et Vasculaire» Thionville, Fr

Assessment of the procedural etiology of stroke resulting from carotid artery stenting

Advances in the treatment of posterior cerebral circulation symptomatic disease

a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS

Emboli detection to evaluate risk of stroke

Surgical treatment for pseudo-occlusion of the internal carotid artery

How Duplex Ultrasound Screening Can Lead to Overuse of Carotid Interventions. No Disclosures. Prevalence >70% Asymptomatic ICA Stenosis*

Which Patients Are Good Candidates for Carotid Artery Stenting or Carotid Endarterectomy

Identification, Prognosis, and Management of Patients with Carotid Artery Near Occlusion

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Surgical Treatment of Carotid Disease

Alma Mater Studiorum Università di Bologna

Feasibility and Safety of Simultaneous Carotid Endarterectomy and Carotid Stenting for Bilateral Carotid Stenosis

Will Mesh-covered Stents Help Reduce the Risk of Stroke? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

Open heart surgery or carotid endarterectomy. Which procedure should be done first?

Carotid Revascularization

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA

Carotid Artery Stenting

Endovascular vs Surgical Carotid Revascularisation

Fast-track CEA: a 3-year experience

Review of clinical carotid stent procedural & long-term outcomes in. symptomatic asymptomatic. patients

New concepts for filter protection during CAS: double filtration. Alberto Cremonesi MD, FESC

Co chce/čeká neurochirug od anesteziologa během karotické endarterektomie?

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Protokollanhang zur SPACE-2-Studie Neurology Quality Standards

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough

ORIGINAL CONTRIBUTION. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

ORIGINAL CONTRIBUTION

AN ASSESSMENT OF INTER-RATER RELIABILITY IN THE TREATMENT OF CAROTID ARTERY STENOSIS

Carotid Artery Stenting

Carotid Endarterectomy after Ischemic Stroke Is there a Justification for Delayed Surgery?

New ischemic brain lesions on DW-MRI after CAS with double layer stent

Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC

Surgical Procedures for. Symptomatic Post-CAS Carotid. Restenosis: Experiences and. Mid-Term Outcomes. Lefeng Qu M.D., Ph.D. Professor of Surgery

Update : Carotid Stenting and Current Trial Data

I have the following potential conflicts of interest to report. honorarium: 1. St Jude Medical 2. Biotronik 3. Boston Scientific

The Effectiveness of Medical Therapy for Severe Carotid Stenosis in Reducing Large-Vessel Embolic Stroke: Open Question or Question Answered?

Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in a Patient with Carotid Disease

Lecture Outline: 1/5/14

Michael Horowitz, MD Pittsburgh, PA

collaterals offset ischemia

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Contemporary Carotid Imaging and Approach to Treatment: Course Notes Thursday, June 22, 2017 David M. Pelz, MD, FRCPC

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Carotid Stenosis 1/24/2019. Review of Primary Studies. NASCET- Moderate stenosis. ACAS (Asymptomatic Carotid Atherosclerosis Study) NASCET

Extra- and intracranial tandem occlusions in the anterior circulation - clinical outcome of endovascular treatment in acute major stroke.

The contribution of the external carotid artery to cerebral perfusion in carotid disease

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Categorical Course: Update of Doppler US 8 : 00 8 : 20

Carotid artery occlusion: Positive predictive value of duplex sonography compared with arteriography

Transcription:

Internal carotid artery near-total occlusions: Is it justified to operate on them? Christos D. Liapis Professor (Em) of Vascular Surgery Athens University Medical School Director Vascular & Endovascular Clinic Athens Medical Center

NO DISCLOSURES RELATED TO THE TOPIC

ICA near total occlusion synonyms critical stenosis, near total occlusion, sub-occlusion, pre-occlusion, pseudo-occlusion, string sign, slim sign lotus root sign Lee et.al., Neurological Science, 2012

ICA near total occlusion M, 70-y, recently symptomatic

ICA near total occlusion M, 70-y, recently symptomatic

Radiological criteria for the diagnosis of ICA near total occlusion reduction in ICA diameter compared with the ipsilateral ECA obviously reduced diameter of the ICA compared with the contralateral ICA

Radiological criteria for the diagnosis of ICA near total occlusion intracranial collaterals seen as cross-filling of contralateral vessels or ipsilateral contrast dilution delayed cranial arrival of ICA contrast compared with that of the ECA Fox. et.al., American Journal of Neuroradiology, 2005

Carotid Pseudo-Occlusion in Hyperacute Stroke Acute stroke patients with an apparent tandem occlusion on conventional single-phase CTA can have delayed antegrade ICA flow on 4D-CTA. 4D-CTA is a novel noninvasive technique that can identify carotid pseudo-occlusion in the acute stroke setting. Ng FC et.al J Neuroimaging. 2016

Natural history of ICA near total occlusion Incidence: 4.3% (NASCET, ECST) Risk of stroke: 6.2% per year Progression to occlusion 40% at 12 months: Radak et.al, Ann Vasc Surg 2010 100% at 34 months: O'Leary et al, Stroke 1989

Outcomes associated with carotid pseudo-occlusion 500 patients were examined for CS by cerebral angiography; those with severe CS 70% (CS group) or with PO (PO group) were enrolled in this study. The primary endpoint was defined as the combined endpoint of the occurrence of stroke, myocardial infarction, or death. Patients without any events were censored at 60 months. CONCLUSION: Patients in the PO group more frequently had neurological and cardiac events or died compared with those in the CS group (p = 0.013). Ogata T. et.al Cerebrovasc Dis. 2011

ICA near total occlusion Pooled data from NASCET, ECST, VA: 5-year risk of any stroke among symptomatic patients No benefit of surgery over BMT for symptomatic patients with string sign Rothwell et.al, Lancet, 2003

String sign carotids are excluded from recent RCTs!!! ICSS, 2010 CREST, 2010 CREST- 2 32. "String sign" of the ipsilateral common or internal carotid artery.

Is the surgical management of near total occlusion of the internal carotid artery justified?

Management of Patients with Internal Carotid Artery Near-total Occlusion: An Updated Meta-analysis S.N. Mylonas, C.N. Antonopoulos, K.G. Moulakakis, J.D. Kakisis, C.D. Liapis Ann Vasc Surg 2015

S.N. Mylonas, C.N. Antonopoulos, K.G. Moulakakis, J.D. Kakisis, C.D. Liapis Ann Vasc Surg 2015 Management of Patients with Internal Carotid Artery Near-total Occlusion: An Updated Meta-analysis CEA 15 studies, 774 patients CAS 10 studies, 342 patients BMT 5 studies, 186 patients Author, year Ogata, 2011 Radak, 2010 Bowman, 2009 Fox, 2005 Greiner, 2004 Ascher, 2002 Samson, 1999 Pulli, 1997 Regina, 1997 Kniemeyer 1996 Archie, 1994 Berman, 1994 Fredericks, 1990 O'Leary, 1989 Ringelstein, 1983 CEA (n) 28 259 1 148 40 12 5 24 15 76 17 91 26 25 7 Author, year CAS (n) Ruiz-Salmerón, 2013 54 Sakamoto, 2013 14 Son, 2013 24 Spacek, 2012 19 Gonzalez, 2011 116 Barker, 2010 9 Choi, 2010 48 Razuk, 2010 13 Nikas, 2010 25 Terada, 2006 20 Author, year BMT (n) Radak et al 2010 50 Bowman et al, 2009 8 Fox et al, 2005 114 Ascher et al, 2002 5 O'Leary et al, 1989 9

ICA near total occlusion Should we treat? CEA or BMT Crude Incidence Rates Risk of stroke Incidence Rates per year P<0.01 P<0.01 CEA 5.5% BMT 14% CEA 2.2% BMT 6.2% S.N. Mylonas, C.D. Liapis et.al Ann Vasc Surg 2015

ICA near total occlusion Should we treat? CAS or BMT Crude Incidence Rates Risk of stroke Incidence Rates per year P<0.01 P<0.01 CAS 4.4% BMT 14% CAS 1.8% BMT 6.2% S.N. Mylonas, C.D. Liapis et.al Ann Vasc Surg 2015

ICA near total occlusion Results of meta-analysis on CAS and CEA Crude Incidence Rates (%) Outcome CAS CEA % (95%CI) % (95%CI) p value TIA 2.1 (0.9-3.8) 3.5 (1.4-6.6) 0.35 Stroke 4.4 (2.5-6.8) 5.5 (2.8-9.0) 0.58 Stroke-related Death 1.5 (0.5-3.0) 1.9 (0.7-3.6) 0.72 MI 3.1 (1.5-5.1) 2.5 (1.0-4.7) 0.65 Overall Mortality 9.3 (6.5-12.6) 6.4 (2.6-11.84) 0.31 MAE 8.4 (5.7-11.5) 7.3 (4.0-11.53) 0.64 Restenosis 4.4 (2.5-6.8) 13.0 (5.4-23.4) 0.03 No differences in TIA, Stroke, Stroke-Related Death, MI, Mortality, MAE Significantly lower restenosis after CAS, compared to CEA S.N. Mylonas, C.D. Liapis et.al Ann Vasc Surg 2015

Possible moderators of Restenosis Rate The effect of patch No significant effect of the use of patch on Restenosis after CEA S.N. Mylonas, C.D. Liapis et.al Ann Vasc Surg 2015

Possible moderators of Restenosis Rate: Duration of follow-up BMT BMT CEA CEA CAS P=0.04 P=n.s CAS Patients treated with CEA had significantly longer follow-up S.N. Mylonas, C.D. Liapis et.al Ann Vasc Surg 2015

Meta-analysis: ICA near total occlusion Small, Retrospective No report on time between operation and restenosis for all studies Limitations of included studies Absence of control group Short duration of follow-up Control Case Selection bias Different Definitions of near occlusion S.N. Mylonas, C.D. Liapis et.al Ann Vasc Surg 2015

ICA near total occlusion Limitations of meta-analysis Outliers? Restenosis after CEA Heterogeneity S.N. Mylonas, C.D. Liapis et.al Ann Vasc Surg 2015

Endovascular Treatment for Near Occlusion of the Internal Carotid Artery : 30-Day Outcome and Long-Term Follow-Up MATERIAL AND METHODS: Between 2004-2014 a total of 182 patients with ICA NO were evaluated for CAS. The study included 132 male (72.5 %) and 50 female (27.5 %) patients with a mean age of 70.2 years. Of the patients 80 (44 %) were asymptomatic. The median clinical and carotid Doppler ultrasound (DUS) follow-up period was 64 months (range 18-124 months). RESULTS: Technical success 100%!! 4 patients (2.2 %) developed minor stroke, 2 patients (1.1 %) developed myocardial infarction but no major stroke or death occurred in the following 30- day period. Asymptomatic restenosis was detected in seven patients (3.8 %). CONCLUSION: With sufficient neurological evaluation during pretreatment and post treatment and when the procedure is performed with technologically developed products by an experienced interventional team, CAS is beneficial in patients with ICA NO Akkan K. et.al Clin Neuroradiol. 2016

Conclusions ICA near total occlusion is a frequent finding with a reported potential to progress to total occlusion up to 40% per year and with an incidence of stroke up to 6% per year

Conclusions Our meta-analysis evidenced that BMT presents increased Stroke Incidence Rates, compared to CEA or CAS!!!

Conclusions Literature review indicates similar stroke rates and significantly lower restenosis during short-term follow-up after CAS, compared to CEA

Conclusions We must include patients with ICA near total occlusion in the RCTs In the meantime Surgical treatment of patients with carotid near total occlusion is justified on a selected basis.

Thank you for your attention Athens 10/1/2017